Russia Healthcare and Medicine Tenders

The Russian healthcare and medicine market is a behemoth, projected to reach $33.3 billion by 2026. This growth is driven by factors like an aging population, rising disposable incomes, and government focus on improving healthcare infrastructure.
Key figures:
$29.0 billion market size in 2020
5.3% CAGR growth rate
$138 billion healthcare expenditure in 2022 (6.5% of GDP)

The Russian government is the biggest spender in the healthcare and medicine market, accounting for over 50% of total spending. This procurement is done through a centralized system to ensure transparency and efficiency.
Key figures:
$45 billion government procurement spending in 2022
10% annual growth rate
Focus on domestic manufacturers and import substitution

The Russian government procures a wide range of healthcare and medicine products and services, including:
Pharmaceuticals: $26.6 billion market size in 2022
Medical devices: $11.4 billion market size in 2020
Medical services: $7.3 billion market size in 2020

Ministry of Health of the Russian Federation: Sets policies and regulations for healthcare procurement.
Federal Compulsory Medical Insurance Fund (FMIF): Responsible for purchasing healthcare services for insured citizens.
Federal Service for Surveillance in Healthcare (Roszdravnadzor): Oversees the quality and safety of medical products and services.

Top Local Winners of russia Healthcare & Medicine Procurement:
R-Pharm: Major pharmaceutical company developing and manufacturing high-quality medicines.
Stada CIS: Subsidiary of a multinational pharmaceutical company, producing and distributing affordable medicines.
Biomedgroup: Leading distributor of medical equipment and consumables.

Tags -
Russia healthcare medicine tenders, free Russia healthcare medicine tenders, government healthcare medicine tenders Russia, Russia Hospital supply tenders, Russia healthcare consultancy tenders, Russia medicine tenders, Russia hospital tenders, Russia drugs tenders, Russia health services tenders